Securely storing and interpreting the genome

April 19, 2013 by Cécilia Carron

At a time when sequencing the genome is becoming democratized, questions have arisen about the interpretation of these data and their secure storage. Sophia Genetics, an EPFL Science Park start-up, specializes in this. The company recently raised 2.8 million francs.

Complete sequencing of the genome will soon enable personalized treatments. Moreover, new based on are coming on the market. Given the drastic reduction on the cost of , it may even be possible before long to know each person's predisposition to certain diseases, allergies, and food intolerances. Riding on this wave in medicine, Jurgi Camblong, Pierre Hutter and Lars Steinmetz have founded a start-up to securely store this data, which promises to be considerable (one genome contains 3 billion letters or !). Reading the data will be made easier with new software.

The video will load shortly

Launched in September 2012, this new bioinformatics tool is already being used by a dozen hospitals and laboratories in Switzerland. With it, a DNA sample can be taken during a and sent to a specialized laboratory for extraction. The young company based at the Ecublens Science Park has raised 2.8 million francs for development.

View a patient's DNA in the blink of an eye

Once sequenced, the data is transmitted to Sophia Genetics for bioinformatics analysis. The then has access to a to help interpret the data. Other applications for viewing and performing electronic biopsies of all parts of the genome are currently being developed.

How is it possible to ensure that a person's will not be disclosed, for example to insurance companies and employers? The company has worked to standardize and automate the analysis and storage of data in two data centers in Switzerland. With the laboratory of Professor Jean-Pierre Hubaux at EPFL, the start-up is developing a high security storage that may be necessary in the future. One of the main elements of confidentiality is to provide the patient with a cryptographic key that comes in two parts for each sequencing. The patient would give one part to Sophia Genetics and the other to the physician so that the data could only be read when the patient has given consent.

Sophia Genetics aims high: to cover 80% of the Swiss market in the field of diagnostics by the end of the year and then extend to the European market, which could reach 500 million francs by 2015. Jurgi Camblong believes that users have a vested interest in having a web host and a common software in order to standardize laboratory procedures.

Explore further: Future of personalized cancer care is promising and near

Related Stories

Future of personalized cancer care is promising and near

April 19, 2011

Cancer survival rates could improve soon with whole-genome sequencing, according to two studies published in the April 20, 2011, issue of the Journal of the American Medical Association that describe the first clinical applications ...

The '$1,000 genome' may cost $100,000 to understand

May 11, 2011

Advances in technology have almost lifted the curtain on the long-awaited era of the "$1,000 genome" — a time when all the genes that make up a person can be deciphered for about that amount – compared to nearly ...

Science of genome-sequencing marks 10 years

April 15, 2013

A decade after completion of the Human Genome Project on April 14, 2003, a top official of the National Institutes of Health surveyed the rarefied view from that mountaintop:

Recommended for you

New genetic clues into motor neuron disease

July 26, 2016

Researchers at The University of Queensland have contributed to the discovery of three new genes which increase the risk of motor neuron disease (MND), opening the door for targeted treatments.

Genome-editing 'toolbox' targets multiple genes at once

July 26, 2016

A Yale research team has designed a system to modify, or edit, multiple genes in the genome simultaneously, while also minimizing unintended effects. The gene-editing "toolbox" provides a user-friendly solution that scientists ...

Chinese team to pioneer first human CRISPR trial

July 22, 2016

(Medical Xpress)—A team of researchers at Sichuan University's West China Hospital has announced plans to begin a clinical trial where cells modified using the CRISPR gene editing technique will be used on human beings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.